Lung transplantation for silicosis: a case study
Transplant Journal of Australasia · 2019
DOI: 10.33235/tja.28.2.13-17 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Journal of Australasia, 2019. Verfasst von Kate McEwen und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Lung transplantation has become a well-established treatment for a variety of end-stage pulmonary diseases. Silicosis is a rare indication for lung transplantation; however, there is currently no other treatment available for the disease in its end stages. This case study presents a 52-year-old man who presented with silicosis for lung transplantation. His in-hospital recovery journey is examined and discussion is provided about his experience of complications, including type 2 respiratory failure and non-compliance with non-invasive ventilation therapy. The patient education and support provided, particularly related to medication management following transplantation surgery, if of key importance during the transplant recipient’s recovery. The social situation and its implications for both the patient and their family should also be considered. Both these aspects are also explored in the context of the case presented.
Zitieren
APA
McEwen, K., & Brodie, L. (2019). Lung transplantation for silicosis: a case study. Transplant Journal of Australasia. https://doi.org/10.33235/tja.28.2.13-17
Vancouver
McEwen K, Brodie L. Lung transplantation for silicosis: a case study. Transplant Journal of Australasia. 2019. doi:10.33235/tja.28.2.13-17
BibTeX
@article{McEwen2019,
author = {McEwen, Kate and Brodie, Lyndell},
title = {Lung transplantation for silicosis: a case study},
journal = {Transplant Journal of Australasia},
year = {2019},
doi = {10.33235/tja.28.2.13-17}
}
EUVIMED